Researchers at Stanford University, in the United States, claimed to have created a molecule capable of eliminating an aggressive type of lymphoma in rats in just 11 days. The treatment, when applied twice a day, was able to completely eliminate the tumor in less than two weeks.
The molecule works by redirecting one of the most common proteins responsible for B-cell lymphoma to activate cell death. According to the scientists, the goal is to fight cancer at its cause, eliminating the driving force of the disease and reprogramming it to activate cell death mechanisms.
Gerald Crabtree, professor of Pathology and Developmental Biology at the university, explained that the approach essentially seeks to reprogram the mechanism that causes cancer so that it itself activates the death of diseased cells.
